Hokuriku Pharmaceutical (300016.SZ) obtained pioglitazone metformin tablet registration certificate

Zhitong Finance App News, Hokuriku Pharmaceutical (300016.SZ) announced that the company received the “Drug Registration Certificate” for pioglitazone metformin tablets (15mg/500mg) approved and issued by the State Drug Administration. On the basis of diet control and exercise, this product is suitable for type 2 diabetics currently treated with pioglitazone hydrochloride in combination with metformin hydrochloride or type 2 diabetics with poor blood sugar control after treatment with metformin hydrochloride alone.